BioNTech and Autolus Announce Strategic Alliance to Bolster CAR-T Cell Pipeline

No Comments

BioNTech will invest $200 million and get access to Autolus’ manufacturing sites.

Medicine

Leave a Reply

Your email address will not be published. Required fields are marked *